Pulse Biosciences (PLSE) Cash from Financing Activities (2017 - 2025)

Pulse Biosciences' Cash from Financing Activities history runs 9 years deep, the most recent figure standing at $381000.0 for Q4 2025.

• In Q4 2025, Cash from Financing Activities fell 99.21% year-over-year to $381000.0; the TTM figure through Dec 2025 stood at $17.2 million (down 84.43% YoY), while the FY2025 annual figure was $17.2 million, down 84.43% from the prior year.
• Cash from Financing Activities for Q4 2025 stood at $381000.0, down from $2.0 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $65.1 million in Q3 2022, with the low at -$549000.0 in Q4 2021.
• The 5-year median for Cash from Financing Activities is $2.1 million (2023), against an average of $15.1 million.
• The sharpest annual moves came in 2021 and 2023: Cash from Financing Activities jumped 19278.03% in 2021, then plunged 564.62% in 2023.
• Pulse Biosciences' Cash from Financing Activities stood at -$549000.0 in 2021, then soared by 96.9% to -$17000.0 in 2022, then jumped by 4829.41% to $804000.0 in 2023, then surged by 5895.27% to $48.2 million in 2024, then sank by 99.21% to $381000.0 in 2025.
• Business Quant data shows PLSE's Cash from Financing Activities at $381000.0 in Q4 2025, $2.0 million in Q3 2025, and $14.8 million in Q1 2025.